Merck
Trade Merck 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRK
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other.
MRK Key Statistics
Stock Snapshot
With a market cap of 329.62B, Merck(MRK) trades at $133.43. The stock has a price-to-earnings ratio of 135.63 and currently yields dividends of 2.56%.
As of 2026-11-20, Merck(MRK) stock has fluctuated between $132.37 and $137.17. The current price stands at $133.43, placing the stock +0.8% above today's low and -2.7% off the high.
The Merck(MRK)'s current trading volume is 15.61M, compared to an average daily volume of 8.69M.
During the past year, Merck(MRK) stock moved between $93.90 at its lowest and $156.92 at its peak.
During the past year, Merck(MRK) stock moved between $93.90 at its lowest and $156.92 at its peak.
MRK News
...
Merck & Co. Inc. (NYSE:MRK) on Friday announced that its pivotal Phase 3 TroFuse-015 trial met its primary endpoint of overall survival (OS). Evaluating sacitu...
Owning Merck directly means you carry company specific issues by yourself, such as a dividend that Simply Wall St says is not well covered by earnings, or profi...
Analyst ratings
65%
of 31 ratingsMore MRK News
This week's dividend activity included increased payouts from Merck (MRK) and Walt Disney (DIS) as well as declarations from Nvidia (NVDA) and Nike (NKE). Addi...
Merck (MRK) announced the pivotal Phase 3 TroFuse-015 trial evaluating sacituzumab tirumotecan, an investigational TROP2-directed antibody-drug conjugate licens...
Merck (NYSE:MRK) announced a new AI-focused drug discovery collaboration with Alphabet unit Isomorphic Labs centered on oncology research. The company said it...
Halozyme (HALO) provided an update on the German preliminary injunction hearing that overturned the decision issued in December 2025, ordering Merck (MRK) to re...
Merck (MRK) is joining hands with AI-driven drug discovery firm Isomorphic Labs to discover drug candidates against cancer, the companies announced on Thursday....
Merck (MRK) and Isomorphic Labs, an AI-first drug design and development company, announced a research collaboration that brings together Isomorphic Labs’ AI ap...
Merck & Company ( (MRK) ) has provided an announcement. On Nov. 16, 2026, Thomas H. Glocer notified Merck of his intention to retire from its board at the May...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.